United Therapeutics Form 144 Notice — 1,000 Shares to Be Sold on 09/24/2025

Rhea-AI Filing Summary

The filing is a Form 144 notice for proposed sale of 1,000 shares of common stock to be sold through Morgan Stanley Smith Barney LLC on 09/24/2025 with an aggregate market value of $440,000.00. The securities were acquired and paid for on 09/24/2025 by stock option exercise. The filing shows 45,226,262 shares outstanding for the issuer. The notice discloses prior sales by an identified seller of 3,000 shares on 09/02/2025 for gross proceeds of $1,269,630.00. The signer represents they have no material nonpublic information regarding the issuer.

Positive

• Timely and complete Rule 144 disclosure including broker, acquisition method, and sale date
• Explicit representation that the filer does not possess undisclosed material information

Negative

• Insider liquidity event: planned sale of 1,000 shares valued at $440,000, and prior sale of 3,000 shares for $1,269,630, which increases insider share supply

Insights

Securities Analyst

TL;DR: Routine insider exercise and planned sale of 1,000 shares; not a material capital-market event by itself.

The Form 144 documents a same-day stock option exercise and planned brokered sale of 1,000 shares valued at $440,000, indicating an insider liquidity event executed through Morgan Stanley Smith Barney. The filing also lists recent insider sales of 3,000 shares on 09/02/2025 totaling $1,269,630, which shows prior disposition activity. For investors, these are disclosure items that increase share supply from insiders but do not by themselves provide information about company performance or forecasts because the filer affirms no undisclosed material information.

Corporate Governance Expert

TL;DR: Proper Rule 144 disclosure of option exercise and planned sale; filing includes required representations about material information.

The document complies with Rule 144 format: it identifies the broker, transaction type (stock option exercise), acquisition and payment dates, and prior insider sales within three months. The signer affirms the absence of undisclosed material information, which is a standard governance representation. This is a routine compliance disclosure rather than a governance event like a director resignation or related-party transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1000	440000.00	45226262	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/24/2025	Stock Option Exercise	Issuer			1000	09/24/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTOPHER CAUSEY 1000 SPRING STREET SILVER SPRING MD 20910	Common	09/02/2025	3000	1269630.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for UTHR disclose?

The Form 144 discloses a proposed brokered sale of 1,000 common shares on 09/24/2025 valued at $440,000, acquired via stock option exercise on the same date.

Who is the broker handling the proposed sale in the UTHR Form 144?

The broker listed is Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004.

Does the filing show any recent insider sales for UTHR?

Yes. The filing reports a prior sale of 3,000 common shares on 09/02/2025 that generated gross proceeds of $1,269,630.00.

How many shares outstanding does the issuer report in this Form 144?

The issuer's reported number of shares outstanding in the filing is 45,226,262.

What acquisition method is listed for the securities to be sold?

The securities were acquired through a stock option exercise on 09/24/2025, and payment was made in cash on the same date.